Drug Type Small molecule drug |
Synonyms ABBV 553 |
Target |
Action antagonists |
Mechanism RORG antagonists(Nuclear receptor ROR-gamma antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Phase 1 | United States | 09 May 2017 |